In this study, CD suppressed ADAM17 expression, especially in lung cancer, which supports the possibility of developing anti-SARS-CoV-2 drugs and suggests a role for CD in anti-SARS-CoV-2 therapy in cancer patients by inhibiting ADAM17 expression. The gene discussed is ADAM17; the disease is cancer.